The patient had no history of a convulsive disorder, but he was known to have had benign, essential hypertension for ... that may have led to the acute encephalopathy in the 2 cases reported ...

Severe acute hypertension occurring with end ... may also result in impaired cerebral perfusion and precipitate hypertensive encephalopathy. Although once considered a first-line agent in ...

Purpose. Intravenous antihypertensive agents for the treatment of hypertensive emergencies are reviewed. Summary. An estimated 500,000 people in the United States experience a hypertensive crisis ...

Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of four posters and one oral presentation on TERLIVAZ® (terlipressin) for injection in patients with ...

Patients with volume overload or with acute-on-chronic liver failure (ACLF) Grade 3 are at increased risk. Assess oxygenation saturation (e.g., SpO 2) before initiating TERLIVAZ. Do not initiate ...

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

LONDON, April 23, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...

Blogging Stroke highlights high-impact studies published in the journal Stroke. In addition to article summaries, Blogging Stroke includes interviews with authors of recently published Stroke articles ...

Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis ...